Skip to main content Accessibility help


  • Pierre Loge (a1), François Delalande (a2), Marie-Christine Reymond (a2) and Sylvia Germain (a2)


Objectives: This study aims to analyze the key factors considered for the first application of the National Committee for the Evaluation of Medical Devices (CNEDiMTS) for achieving reimbursement through registration in the list of products and services qualifying for reimbursement (LPPR).

Methods: All the appraisals studied on medical devices (MD) for first inclusion in the LPPR during 2011 and 2012 were retrieved from the French National Authority for Health or Haute Autorité de santé (HAS) Web site. A list of relevant factors was analyzed for each included opinion, followed by univariate and multivariate analyses to highlight the key factors that impacted the expected benefit (EB) provided by HAS.

Results: A total of 151 appraisals were included in the study. Of them, 94 (62 percent) were granted with sufficient EB. The manufacturers were mostly from the United States (36 percent), while most of the applicants were from France (84 percent). After adjusting for other retrieved factors, it was observed that MDs complying with the technical standards, requests supported by opinion(s) from previous generation of MD, and the presence of recommendations or guidelines had more probability to obtain a sufficient EB. A lower probability was related to MDs supported by low-quality studies and with no specific health public benefit.

Conclusions: Our results confirmed that manufacturers seeking reimbursement should be aware of the expectations of the health authorities (level of evidence, technical standard, etc.) and foresee their plan of sending requests for funding so that they can provide evidence of good quality.



Hide All
1. Haute Autorité de Santé (HAS) [Internet]. Medical device assessment in France: Guidebook. 2009. [updated 2009 October]. (accessed January 17, 2014).
2. Haute Autorité de Santé (HAS) [Internet]. Guide to the application dossier for inclusion, for modification of the conditions for inclusion and for the renewal of inclusion of a product or service under a brand name on the list referred to in Article L.165–1 to be submitted to the National Committee for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). 2011. [updated November 8, 2011]. (accessed January 19, 2014).
3. Authority for Health (HAS) [Internet]. Business report 2012. 2013. [updated June 27, 2013]. (accessed January 22, 2014).
4. Sorenson, C, Drummond, M, Kanavos, P. Ensuring value for money in health care. The role of health technology assessment in the European Union [Internet] . Copenhagen, Denmark: WHO Regional Office for Europe; c2008. [updated February 24, 2011]. (accessed January 24, 2014).
5. Haute Autorité de Santé (HAS) [Internet]. Guide pour le dépôt d’un dossier auprès de la Commission nationale d’évaluation des dispositifs médicaux et des technologies de santé (CNEDiMTS). 2015. [updated June 26, 2015]. (accessed January 26, 2014).
6. Haute Autorité de Santé (HAS) [Internet]. Parcours du dispositif medical. Guide pratique. (Course of the medical device. Practical Guide). 2009 actualisation 2013. 2013. [updated October 2009]. (accessed January 28, 2014).
7. Haute Autorité de Santé (HAS) [Internet]. Methodological choices for the clinical development of medical devices- Assessment report. 2013. [updated November 21, 2013]. (accessed February 5, 2014).
8. Stephens, JM, Handke, B, Doshi, JA. International survey of methods used in health technology assessment (HTA): Does practice meet the principles proposed for good research? Comp Eff Res. 2012;2:2944.
9. Haute Autorité de Santé (HAS) [Internet]. Niveau de preuve et gradation des recommandations de bonne pratique (Level of evidence and grading of recommendations for good practice). 2013. [updated 2013 June 14, 2013]. (accessed February 15, 2014).
10. Huot, L, Decullier, E, Maes-Beny, K, Chapuis, FR. Medical device assessment: Scientific evidence examined by the French national agency for health - A descriptive study. BMC Public Health. 2012;12:585.



Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed